title: Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B.
authors.affiliation: Pediatric Intensive Care Unit, Danube Hospital Vienna, Langobardenstr 122, 1220 Vienna, Austria. peter.voitl@smz.magwien.gv.at
authors.forename: P
authors.initials: P
authors.lastname: Voitl
authors.forename: C
authors.initials: C
authors.lastname: Scheibenpflug
authors.forename: T
authors.initials: T
authors.lastname: Weber
authors.forename: O
authors.initials: O
authors.lastname: Janata
authors.forename: A M
authors.initials: AM
authors.lastname: Rokitansky
mesh_terms: D000293:Adolescent; D000666:Amphotericin B / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D000077336:Caspofungin; D004359:Drug Therapy, Combination; D054714:Echinocandins; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D055666:Lipopeptides; D009091:Mucormycosis / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery; D010455:Peptides; D010456:Peptides, Cyclic; D012233:Rhizopus / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010455:Peptides; D010456:Peptides, Cyclic; D000666:Amphotericin B; D000077336:Caspofungin